Performance characteristics of the platelia Aspergillus enzyme immunoassay for detection of Aspergillus galactomannan antigen in bronchoalveolar lavage fluid

S. Husain, C. J. Clancy, M. H. Nguyen, S. Swartzentruber, H. Leather, A. M. LeMonte, M. M. Durkin, Kenneth S Knox, C. A. Hage, C. Bentsen, N. Singh, J. R. Wingard, L. J. Wheat

Research output: Contribution to journalArticle

75 Citations (Scopus)

Abstract

We have evaluated the Platelia Aspergillus enzyme immunoassay for detection of galactomannan in bronchoalveolar lavage (BAL) specimens in solid organ transplant patients with aspergillosis. The precision and reproducibility in serum or BAL to which galactomannan was added were similar. Sensitivity was 81.8% in patients with aspergillosis, and specificity was 95.8% in lung transplant patients who underwent BAL for surveillance for infection or rejection. Among transplant controls, positive results were more common in patients (i) who underwent diagnostic BAL performed for evaluation of symptoms or chest computed tomographic abnormalities, (ii) who had undergone lung transplantation, or (iii) who were colonized with Aspergillus. Galactomannan testing in BAL is useful for diagnosis of aspergillosis in transplant patients. The significance of positive results in patients without confirmed aspergillosis requires further evaluation.

Original languageEnglish (US)
Pages (from-to)1760-1763
Number of pages4
JournalClinical and Vaccine Immunology
Volume15
Issue number12
DOIs
StatePublished - Dec 2008

Fingerprint

Transplants
Aspergillus
Bronchoalveolar Lavage Fluid
Immunoenzyme Techniques
Bronchoalveolar Lavage
Aspergillosis
Antigens
Fluids
Enzymes
Symptom Assessment
Lung Transplantation
galactomannan
Testing
Thorax
Lung
Infection
Serum

ASJC Scopus subject areas

  • Clinical Biochemistry
  • Immunology
  • Immunology and Allergy
  • Microbiology (medical)

Cite this

Performance characteristics of the platelia Aspergillus enzyme immunoassay for detection of Aspergillus galactomannan antigen in bronchoalveolar lavage fluid. / Husain, S.; Clancy, C. J.; Nguyen, M. H.; Swartzentruber, S.; Leather, H.; LeMonte, A. M.; Durkin, M. M.; Knox, Kenneth S; Hage, C. A.; Bentsen, C.; Singh, N.; Wingard, J. R.; Wheat, L. J.

In: Clinical and Vaccine Immunology, Vol. 15, No. 12, 12.2008, p. 1760-1763.

Research output: Contribution to journalArticle

Husain, S, Clancy, CJ, Nguyen, MH, Swartzentruber, S, Leather, H, LeMonte, AM, Durkin, MM, Knox, KS, Hage, CA, Bentsen, C, Singh, N, Wingard, JR & Wheat, LJ 2008, 'Performance characteristics of the platelia Aspergillus enzyme immunoassay for detection of Aspergillus galactomannan antigen in bronchoalveolar lavage fluid', Clinical and Vaccine Immunology, vol. 15, no. 12, pp. 1760-1763. https://doi.org/10.1128/CVI.00226-08
Husain, S. ; Clancy, C. J. ; Nguyen, M. H. ; Swartzentruber, S. ; Leather, H. ; LeMonte, A. M. ; Durkin, M. M. ; Knox, Kenneth S ; Hage, C. A. ; Bentsen, C. ; Singh, N. ; Wingard, J. R. ; Wheat, L. J. / Performance characteristics of the platelia Aspergillus enzyme immunoassay for detection of Aspergillus galactomannan antigen in bronchoalveolar lavage fluid. In: Clinical and Vaccine Immunology. 2008 ; Vol. 15, No. 12. pp. 1760-1763.
@article{b99dda2875454d939c245393b9e5a627,
title = "Performance characteristics of the platelia Aspergillus enzyme immunoassay for detection of Aspergillus galactomannan antigen in bronchoalveolar lavage fluid",
abstract = "We have evaluated the Platelia Aspergillus enzyme immunoassay for detection of galactomannan in bronchoalveolar lavage (BAL) specimens in solid organ transplant patients with aspergillosis. The precision and reproducibility in serum or BAL to which galactomannan was added were similar. Sensitivity was 81.8{\%} in patients with aspergillosis, and specificity was 95.8{\%} in lung transplant patients who underwent BAL for surveillance for infection or rejection. Among transplant controls, positive results were more common in patients (i) who underwent diagnostic BAL performed for evaluation of symptoms or chest computed tomographic abnormalities, (ii) who had undergone lung transplantation, or (iii) who were colonized with Aspergillus. Galactomannan testing in BAL is useful for diagnosis of aspergillosis in transplant patients. The significance of positive results in patients without confirmed aspergillosis requires further evaluation.",
author = "S. Husain and Clancy, {C. J.} and Nguyen, {M. H.} and S. Swartzentruber and H. Leather and LeMonte, {A. M.} and Durkin, {M. M.} and Knox, {Kenneth S} and Hage, {C. A.} and C. Bentsen and N. Singh and Wingard, {J. R.} and Wheat, {L. J.}",
year = "2008",
month = "12",
doi = "10.1128/CVI.00226-08",
language = "English (US)",
volume = "15",
pages = "1760--1763",
journal = "Clinical and Vaccine Immunology",
issn = "1556-6811",
publisher = "American Society for Microbiology",
number = "12",

}

TY - JOUR

T1 - Performance characteristics of the platelia Aspergillus enzyme immunoassay for detection of Aspergillus galactomannan antigen in bronchoalveolar lavage fluid

AU - Husain, S.

AU - Clancy, C. J.

AU - Nguyen, M. H.

AU - Swartzentruber, S.

AU - Leather, H.

AU - LeMonte, A. M.

AU - Durkin, M. M.

AU - Knox, Kenneth S

AU - Hage, C. A.

AU - Bentsen, C.

AU - Singh, N.

AU - Wingard, J. R.

AU - Wheat, L. J.

PY - 2008/12

Y1 - 2008/12

N2 - We have evaluated the Platelia Aspergillus enzyme immunoassay for detection of galactomannan in bronchoalveolar lavage (BAL) specimens in solid organ transplant patients with aspergillosis. The precision and reproducibility in serum or BAL to which galactomannan was added were similar. Sensitivity was 81.8% in patients with aspergillosis, and specificity was 95.8% in lung transplant patients who underwent BAL for surveillance for infection or rejection. Among transplant controls, positive results were more common in patients (i) who underwent diagnostic BAL performed for evaluation of symptoms or chest computed tomographic abnormalities, (ii) who had undergone lung transplantation, or (iii) who were colonized with Aspergillus. Galactomannan testing in BAL is useful for diagnosis of aspergillosis in transplant patients. The significance of positive results in patients without confirmed aspergillosis requires further evaluation.

AB - We have evaluated the Platelia Aspergillus enzyme immunoassay for detection of galactomannan in bronchoalveolar lavage (BAL) specimens in solid organ transplant patients with aspergillosis. The precision and reproducibility in serum or BAL to which galactomannan was added were similar. Sensitivity was 81.8% in patients with aspergillosis, and specificity was 95.8% in lung transplant patients who underwent BAL for surveillance for infection or rejection. Among transplant controls, positive results were more common in patients (i) who underwent diagnostic BAL performed for evaluation of symptoms or chest computed tomographic abnormalities, (ii) who had undergone lung transplantation, or (iii) who were colonized with Aspergillus. Galactomannan testing in BAL is useful for diagnosis of aspergillosis in transplant patients. The significance of positive results in patients without confirmed aspergillosis requires further evaluation.

UR - http://www.scopus.com/inward/record.url?scp=57349095229&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=57349095229&partnerID=8YFLogxK

U2 - 10.1128/CVI.00226-08

DO - 10.1128/CVI.00226-08

M3 - Article

C2 - 18845830

AN - SCOPUS:57349095229

VL - 15

SP - 1760

EP - 1763

JO - Clinical and Vaccine Immunology

JF - Clinical and Vaccine Immunology

SN - 1556-6811

IS - 12

ER -